Top

EJNMMI Research

Published in:

Open Access 01-12-2018 | Original research

[¹¹C]SCH23390 binding to the D₁-dopamine receptor in the human brain—a comparison of manual and automated methods for image analysis

Authors: Per Stenkrona, Granville J. Matheson, Simon Cervenka, Pontus Plavén Sigray, Christer Halldin, Lars Farde

Published in: EJNMMI Research | Issue 1/2018

Abstract

Background

The D₁-dopamine receptor radioligand [¹¹C]SCH23390 has been frequently used in PET studies. In drug-naïve patients with schizophrenia, the findings have been inconsistent, with decreases, increases, and no change in the frontal cortex D₁-dopamine receptors. While these discrepancies are likely primarily due to a lack of statistical power in these studies, we speculated that an additional explanation may be the differences due to methods of image analysis between studies, affecting reliability as well as bias between groups.

Methods

Fifteen healthy subjects underwent two PET measurements with [¹¹C]SCH23390 on the same day. The binding potential (BP_ND) was compared using a 95% confidence interval following manual and automated delineation of a region of interest (ROI) as well as with and without frame-by-frame realignment.

Results

Automated target region delineation produced lower BP_ND values, while automated delineation of the reference region yielded higher BP_ND values. However, no significant differences were observed for repeatability using automated and manual delineation methods. Frame-by-frame realignment generated higher BP_ND values and improved repeatability.

Conclusions

The results suggest that the choice of ROI delineation method is not an important factor for reliability, whereas the improved results following movement correction confirm its importance in PET image analysis. Realignment is therefore especially important for measurements in patient populations such as schizophrenia or Parkinson’s disease, where motion artifacts may be more prevalent.

Available only for authorised users

Wagner HN Jr, Burns HD, Dannals RF, Wong DF, Langstrom B, Duelfer T, et al. Imaging dopamine receptors in the human brain by positron tomography. Science. 1983;221:1264–6.CrossRefPubMed

Garnett ES, Firnau G, Nahmias C. Dopamine visualized in the basal ganglia of living man. Nature. 1983;305:137–8.CrossRefPubMed

Howes O, McCutcheon R, Stone J. Glutamate and dopamine in schizophrenia: an update for the 21st century. J Psychopharmacol. 2015;29:97–115. https://doi.org/10.1177/0269881114563634.CrossRefPubMedPubMedCentral

Kambeitz J, Abi-Dargham A, Kapur S, Howes OD. Alterations in cortical and extrastriatal subcortical dopamine function in schizophrenia: systematic review and meta-analysis of imaging studies. Br J Psychiatry. 2014;204:420–9. https://doi.org/10.1192/bjp.bp.113.132308.CrossRefPubMed

Abi-Dargham A, Mawlawi O, Lombardo I, Gil R, Martinez D, Huang Y, et al. Prefrontal dopamine D1 receptors and working memory in schizophrenia. J Neurosci. 2002;22:3708–19.CrossRefPubMed

Abi-Dargham A, Xu X, Thompson JL, Gil R, Kegeles LS, Urban N, et al. Increased prefrontal cortical D(1) receptors in drug naive patients with schizophrenia: a PET study with [(1)(1)C]NNC112. J Psychopharmacol. 2012;26:794–805. https://doi.org/10.1177/0269881111409265.CrossRefPubMed

Okubo Y, Suhara T, Suzuki K, Kobayashi K, Inoue O, Terasaki O, et al. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature. 1997;385:634–6.CrossRefPubMed

Karlsson P, Farde L, Halldin C, Sedvall G. PET study of D(1) dopamine receptor binding in neuroleptic-naive patients with schizophrenia. Am J Psychiatry. 2002;159:761–7.CrossRefPubMed

Kosaka J, Takahashi H, Ito H, Takano A, Fujimura Y, Matsumoto R, et al. Decreased binding of [11C]NNC112 and [11C]SCH23390 in patients with chronic schizophrenia. Life Sci. 2010;86:814–8. https://doi.org/10.1016/j.lfs.2010.03.018.CrossRefPubMed

10.

Hirvonen J, van Erp TG, Huttunen J, Aalto S, Nagren K, Huttunen M, et al. Brain dopamine d1 receptors in twins discordant for schizophrenia. Am J Psychiatry. 2006;163:1747–53. https://doi.org/10.1176/ajp.2006.163.10.1747.CrossRefPubMed

11.

Lidow MS, Goldman-Rakic PS. A common action of clozapine, haloperidol, and remoxipride on D1- and D2-dopaminergic receptors in the primate cerebral cortex. Proc Natl Acad Sci U S A. 1994;91:4353–6.CrossRefPubMedPubMedCentral

12.

Lidow MS, Elsworth JD, Goldman-Rakic PS. Down-regulation of the D1 and D5 dopamine receptors in the primate prefrontal cortex by chronic treatment with antipsychotic drugs. J Pharmacol Exp Ther. 1997;281:597–603.PubMed

13.

Cervenka S. PET radioligands for the dopamine D1-receptor: application in psychiatric disorders. Neurosci Lett. 2018; https://doi.org/10.1016/j.neulet.2018.03.007.

14.

Poels EM, Girgis RR, Thompson JL, Slifstein M, Abi-Dargham A. In vivo binding of the dopamine-1 receptor PET tracers [(1)(1)C]NNC112 and [(1)(1)C]SCH23390: a comparison study in individuals with schizophrenia. Psychopharmacology. 2013;228:167–74. https://doi.org/10.1007/s00213-013-3026-8.CrossRefPubMed

15.

Klein A, Andersson J, Ardekani BA, Ashburner J, Avants B, Chiang MC, et al. Evaluation of 14 nonlinear deformation algorithms applied to human brain MRI registration. NeuroImage. 2009;46:786–802. https://doi.org/10.1016/j.neuroimage.2008.12.037.CrossRefPubMedPubMedCentral

16.

Chow TW, Takeshita S, Honjo K, Pataky CE, St Jacques PL, Kusano ML, et al. Comparison of manual and semi-automated delineation of regions of interest for radioligand PET imaging analysis. BMC Nucl Med. 2007;7:2. https://doi.org/10.1186/1471-2385-7-2.CrossRefPubMedPubMedCentral

17.

Raniga P, Bourgeat P, Fripp J, Acosta O, Villemagne VL, Rowe C, et al. Automated (11)C-PiB standardized uptake value ratio. Acad Radiol. 2008;15:1376–89. https://doi.org/10.1016/j.acra.2008.07.006.CrossRefPubMed

18.

Rosario BL, Weissfeld LA, Laymon CM, Mathis CA, Klunk WE, Berginc MD, et al. Inter-rater reliability of manual and automated region-of-interest delineation for PiB PET. NeuroImage. 2011;55:933–41. https://doi.org/10.1016/j.neuroimage.2010.12.070.CrossRefPubMed

19.

Su Y, D’Angelo GM, Vlassenko AG, Zhou G, Snyder AZ, Marcus DS, et al. Quantitative analysis of PiB-PET with FreeSurfer ROIs. PLoS One. 2013;8:e73377. https://doi.org/10.1371/journal.pone.0073377.CrossRefPubMedPubMedCentral

20.

Wallius E, Tohka J, Hirvonen J, Hietala J, Ruotsalainen U. Evaluation of the automatic three-dimensional delineation of caudate and putamen for PET receptor occupancy studies. Nucl Med Commun. 2008;29:53–65. https://doi.org/10.1097/MNM.0b013e3282f1bba0.CrossRefPubMed

21.

Johansson J, Alakurtti K, Joutsa J, Tohka J, Ruotsalainen U, Rinne JO. Comparison of manual and automatic techniques for substriatal segmentation in 11C-raclopride high-resolution PET studies. Nucl Med Commun. 2016;37:1074–87. https://doi.org/10.1097/MNM.0000000000000559.CrossRefPubMed

22.

23.

Wienhard K, Dahlbom M, Eriksson L, Michel C, Bruckbauer T, Pietrzyk U, et al. The ECAT EXACT HR: performance of a new high resolution positron scanner. J Comput Assist Tomogr. 1994;18:110–8.CrossRefPubMed

24.

Bergstrom M, Boethius J, Eriksson L, Greitz T, Ribbe T, Widen L. Head fixation device for reproducible position alignment in transmission CT and positron emission tomography. J Comput Assist Tomogr. 1981;5:136–41.CrossRefPubMed

25.

Halldin C, Stone-Elander S, Farde L, Ehrin E, Fasth KJ, Langstrom B, et al. Preparation of 11C-labelled SCH 23390 for the in vivo study of dopamine D-1 receptors using positron emission tomography. Int J Radiat Appl Instrum Part A. 1986;37:1039–43.CrossRef

26.

Schain M, Toth M, Cselenyi Z, Stenkrona P, Halldin C, Farde L, et al. Quantification of serotonin transporter availability with [11C]MADAM—a comparison between the ECAT HRRT and HR systems. NeuroImage. 2012;60:800–7. https://doi.org/10.1016/j.neuroimage.2011.12.047.CrossRefPubMed

27.

Friston KJ, Ashburner J, Frith CD, Poline J-B, Heather JD, Frackowiak RSJ. Spatial registration and normalization of images. Hum Brain Mapp. 1995;3:165–89.CrossRef

28.

Studholme C, Hill D, Hawkes DJ. Normalized entropy measure of 3-D medical image alignment. Medical imaging 1998. San Diego; 1998. p. 132–43.

29.

Roland PE, Graufelds CJ, Wåhlin L, Ingelman L, Andersson M, Ledberg A, et al. Human brain atlas: for high-resolution functionel and anatomical mapping. Hum Brain Mapp. 1994;1:173–84.CrossRefPubMed

30.

Mawlawi O, Martinez D, Slifstein M, Broft A, Chatterjee R, Hwang DR, et al. Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum. J Cereb Blood Flow Metab. 2001;21:1034–57.CrossRefPubMed

31.

Fischl B. FreeSurfer. NeuroImage. 2012;62:774–81. https://doi.org/10.1016/j.neuroimage.2012.01.021.CrossRefPubMedPubMedCentral

32.

Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis. I Segmentation Surface Reconstruction Neuroimage. 1999;9:179–94. https://doi.org/10.1006/nimg.1998.0395. PubMedCrossRef

33.

Fischl B, Sereno MI, Dale AM. Cortical surface-based analysis. II: inflation, flattening, and a surface-based coordinate system. NeuroImage. 1999;9:195–207. https://doi.org/10.1006/nimg.1998.0396. CrossRefPubMed

34.

Han X, Jovicich J, Salat D, van der Kouwe A, Quinn B, Czanner S, et al. Reliability of MRI-derived measurements of human cerebral cortical thickness: the effects of field strength, scanner upgrade and manufacturer. NeuroImage. 2006;32:180–94. https://doi.org/10.1016/j.neuroimage.2006.02.051.CrossRefPubMed

35.

Reuter M, Schmansky NJ, Rosas HD, Fischl B. Within-subject template estimation for unbiased longitudinal image analysis. NeuroImage. 2012;61:1402–18. https://doi.org/10.1016/j.neuroimage.2012.02.084.CrossRefPubMedPubMedCentral

36.

Rosas HD, Liu AK, Hersch S, Glessner M, Ferrante RJ, Salat DH, et al. Regional and progressive thinning of the cortical ribbon in Huntington’s disease. Neurology. 2002;58:695–701.CrossRefPubMed

37.

Kuperberg GR, Broome MR, McGuire PK, David AS, Eddy M, Ozawa F, et al. Regionally localized thinning of the cerebral cortex in schizophrenia. Arch Gen Psychiatry. 2003;60:878–88. https://doi.org/10.1001/archpsyc.60.9.878.CrossRefPubMed

38.

Fischl B, Sereno MI, Tootell RB, Dale AM. High-resolution intersubject averaging and a coordinate system for the cortical surface. Hum Brain Mapp. 1999;8:272–84.CrossRefPubMed

39.

Desikan RS, Segonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. NeuroImage. 2006;31:968–80. https://doi.org/10.1016/j.neuroimage.2006.01.021.CrossRefPubMed

40.

Jenkinson M, Beckmann CF, Behrens TE, Woolrich MW, Smith SM. Fsl. NeuroImage. 2012;62:782–90. https://doi.org/10.1016/j.neuroimage.2011.09.015.CrossRefPubMed

41.

Diedrichsen J, Balsters JH, Flavell J, Cussans E, Ramnani N. A probabilistic MR atlas of the human cerebellum. NeuroImage. 2009;46:39–46. https://doi.org/10.1016/j.neuroimage.2009.01.045.CrossRefPubMed

42.

Matheson GJ, Stenkrona P, Cselenyi Z, Plaven-Sigray P, Halldin C, Farde L, et al. Reliability of volumetric and surface-based normalisation and smoothing techniques for PET analysis of the cortex: a test-retest analysis using [11C]SCH-23390. NeuroImage. 2017;155:344–53. https://doi.org/10.1016/j.neuroimage.2017.04.031.CrossRefPubMed

43.

Lammertsma AA, Hume SP. Simplified reference tissue model for PET receptor studies. NeuroImage. 1996;4:153–8.CrossRefPubMed

44.

Kessler LG, Barnhart HX, Buckler AJ, Choudhury KR, Kondratovich MV, Toledano A, et al. The emerging science of quantitative imaging biomarkers terminology and definitions for scientific studies and regulatory submissions. Stat Methods Med Res. 2015;24:9–26. https://doi.org/10.1177/0962280214537333.CrossRefPubMed

45.

Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307–10.CrossRefPubMed

46.

du Prel JB, Hommel G, Rohrig B, Blettner M. Confidence interval or p-value?: part 4 of a series on evaluation of scientific publications. Dtsch Arztebl Int. 2009;106:335–9. https://doi.org/10.3238/arztebl.2009.0335.PubMedPubMedCentralCrossRef

47.

Obuchowski NA, Reeves AP, Huang EP, Wang XF, Buckler AJ, Kim HJ, et al. Quantitative imaging biomarkers: a review of statistical methods for computer algorithm comparisons. Stat Methods Med Res. 2015;24:68–106. https://doi.org/10.1177/0962280214537390.CrossRefPubMed

48.

Thirthalli J, Rajkumar RP. Statistical versus clinical significance in psychiatric research—an overview for beginners. Asian J Psychiatr. 2009;2:74–9. https://doi.org/10.1016/j.ajp.2009.04.004.CrossRefPubMed

49.

Shakespeare TP, Gebski VJ, Veness MJ, Simes J. Improving interpretation of clinical studies by use of confidence levels, clinical significance curves, and risk-benefit contours. Lancet. 2001;357:1349–53. https://doi.org/10.1016/S0140-6736(00)04522-0.CrossRefPubMed

50.

Searle SR. Linear models. New York: Wiley; 1971.

51.

Perlaki G, Horvath R, Nagy SA, Bogner P, Doczi T, Janszky J, et al. Comparison of accuracy between FSL’s FIRST and FreeSurfer for caudate nucleus and putamen segmentation. Sci Rep. 2017;7:2418. https://doi.org/10.1038/s41598-017-02584-5.CrossRefPubMedPubMedCentral

52.

Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. 2002;33:341–55.CrossRefPubMed

53.

Tae WS, Kim SS, Lee KU, Nam EC, Kim KW. Validation of hippocampal volumes measured using a manual method and two automated methods (FreeSurfer and IBASPM) in chronic major depressive disorder. Neuroradiology. 2008;50:569–81. https://doi.org/10.1007/s00234-008-0383-9.CrossRefPubMed

54.

McCarthy CS, Ramprashad A, Thompson C, Botti JA, Coman IL, Kates WR. A comparison of FreeSurfer-generated data with and without manual intervention. Front Neurosci. 2015;9:379. https://doi.org/10.3389/fnins.2015.00379.CrossRefPubMedPubMedCentral

55.

Rousset O, Rahmim A, Alavi A, Zaidi H. Partial volume correction strategies in PET. PET Clin. 2007;2:235–49. https://doi.org/10.1016/j.cpet.2007.10.005.CrossRefPubMed

56.

Cardinale F, Chinnici G, Bramerio M, Mai R, Sartori I, Cossu M, et al. Validation of FreeSurfer-estimated brain cortical thickness: comparison with histologic measurements. Neuroinformatics. 2014;12:535–42. https://doi.org/10.1007/s12021-014-9229-2.CrossRefPubMed

57.

Nugent AC, Luckenbaugh DA, Wood SE, Bogers W, Zarate CA Jr, Drevets WC. Automated subcortical segmentation using FIRST: test-retest reliability, interscanner reliability, and comparison to manual segmentation. Hum Brain Mapp. 2013;34:2313–29. https://doi.org/10.1002/hbm.22068.CrossRefPubMed

58.

Hirvonen J, Nagren K, Kajander J, Hietala J. Measurement of cortical dopamine d1 receptor binding with 11C[SCH23390]: a test-retest analysis. J Cereb Blood Flow Metab. 2001;21:1146–50.CrossRefPubMed

59.

Kaller S, Rullmann M, Patt M, Becker GA, Luthardt J, Girbardt J, et al. Test-retest measurements of dopamine D1-type receptors using simultaneous PET/MRI imaging. Eur J Nucl Med Mol Imaging. 2017;44:1025–32. https://doi.org/10.1007/s00259-017-3645-0.CrossRefPubMed

60.

Nyberg S, Farde L, Halldin C. Test-retest reliability of central [11C]raclopride binding at high D2 receptor occupancy. A PET study in haloperidol-treated patients. Psychiatry Res. 1996;67:163–71.CrossRefPubMed

61.

Sudo Y, Suhara T, Inoue M, Ito H, Suzuki K, Saijo T, et al. Reproducibility of [11 C]FLB 457 binding in extrastriatal regions. Nucl Med Commun. 2001;22:1215–21.CrossRefPubMed

62.

Lundberg J, Halldin C, Farde L. Measurement of serotonin transporter binding with PET and [11C]MADAM: a test-retest reproducibility study. Synapse. 2006;60:256–63. https://doi.org/10.1002/syn.20297.CrossRefPubMed

63.

Nord M, Finnema SJ, Schain M, Halldin C, Farde L. Test-retest reliability of [11C]AZ10419369 binding to 5-HT(1B) receptors in human brain. Eur J Nucl Med Mol Imaging. 2014;41:301–7. https://doi.org/10.1007/s00259-013-2529-1.CrossRefPubMed

64.

Haukvik UK, Hartberg CB, Agartz I. Schizophrenia—what does structural MRI show? Tidsskr Nor Laegeforen. 2013;133:850–3. https://doi.org/10.4045/tidsskr.12.1084. CrossRefPubMed

65.

Olabi B, Ellison-Wright I, McIntosh AM, Wood SJ, Bullmore E, Lawrie SM. Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies. Biol Psychiatry. 2011;70:88–96. https://doi.org/10.1016/j.biopsych.2011.01.032.CrossRefPubMed

66.

Teipel SJ, Grothe M, Lista S, Toschi N, Garaci FG, Hampel H. Relevance of magnetic resonance imaging for early detection and diagnosis of Alzheimer disease. Med Clin North Am. 2013;97:399–424. https://doi.org/10.1016/j.mcna.2012.12.013.CrossRefPubMed

67.

Politis M. Neuroimaging in Parkinson disease: from research setting to clinical practice. Nat Rev Neurol. 2014;10:708–22. https://doi.org/10.1038/nrneurol.2014.205.CrossRefPubMed

68.

Aylward EH. Magnetic resonance imaging striatal volumes: a biomarker for clinical trials in Huntington’s disease. Mov Disord. 2014;29:1429–33. https://doi.org/10.1002/mds.26013.CrossRefPubMedPubMedCentral

69.

Steenwijk MD, Amiri H, Schoonheim MM, de Sitter A, Barkhof F, Pouwels PJW, et al. Agreement of MSmetrix with established methods for measuring cross-sectional and longitudinal brain atrophy. Neuroimage Clin. 2017;15:843–53. https://doi.org/10.1016/j.nicl.2017.06.034.CrossRefPubMedPubMedCentral

Title: [11C]SCH23390 binding to the D1-dopamine receptor in the human brain—a comparison of manual and automated methods for image analysis
Authors: Per Stenkrona
Granville J. Matheson
Simon Cervenka
Pontus Plavén Sigray
Christer Halldin
Lars Farde
Publication date: 01-12-2018
Publisher: Springer Berlin Heidelberg
Published in: EJNMMI Research / Issue 1/2018
Electronic ISSN: 2191-219X
DOI: https://doi.org/10.1186/s13550-018-0416-2

At a glance: The STEP trials

Springer Medicine

[¹¹C]SCH23390 binding to the D₁-dopamine receptor in the human brain—a comparison of manual and automated methods for image analysis

Abstract

Background

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2018

Glucose metabolic brain patterns to discriminate amyotrophic lateral sclerosis from Parkinson plus syndromes

Histamine H3 receptor density is negatively correlated with neural activity related to working memory in humans

Validation of [18F]FLT as a perfusion-independent imaging biomarker of tumour response in EGFR-mutated NSCLC patients undergoing treatment with an EGFR tyrosine kinase inhibitor

[18F]Fluciclovine PET discrimination between high- and low-grade gliomas

It is time to move forward into the era of Theranostics

Labeling of DOTA-conjugated HPMA-based polymers with trivalent metallic radionuclides for molecular imaging